ArticleTranslational lung cancer research2024

Challenges and considerations in the immunotherapy of DLL3-positive small-cell lung cancer using IL-18 armoured chimeric antigen receptor T-cells.

Roberta Mazza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.